Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1988 1
1990 10
1991 5
1992 6
1993 5
1994 9
1995 5
1996 7
1997 2
1998 12
1999 9
2000 6
2001 16
2002 25
2003 35
2004 55
2005 59
2006 79
2007 128
2008 138
2009 165
2010 162
2011 202
2012 244
2013 331
2014 561
2015 726
2016 812
2017 938
2018 1199
2019 1471
2020 1850
2021 2197
2022 2855
2023 2943
2024 1326

Text availability

Article attribute

Article type

Publication date

Search Results

16,295 results

Results by year

Filters applied: . Clear all
Page 1
lncRNA SYTL5-OT4 promotes vessel co-option by inhibiting the autophagic degradation of ASCT2.
Wen Q, Huang M, Xie J, Liu R, Miao Q, Huang J, Zhang J, Lyu W, Qi M, Wu C, Qi Q, Zhang Z, Deng R, Wang C, Chen ZS, Zhang D, Ye W, Chen M. Wen Q, et al. Drug Resist Updat. 2023 Jul;69:100975. doi: 10.1016/j.drup.2023.100975. Epub 2023 May 13. Drug Resist Updat. 2023. PMID: 37207473 Free article.
AIMS: Vessel co-option is responsible for tumor resistance to antiangiogenic therapies (AATs) in patients with colorectal cancer liver metastasis (CRCLM). However, the mechanisms underlying vessel co-option remain largely unknown. Herein, we investigated the roles o …
AIMS: Vessel co-option is responsible for tumor resistance to antiangiogenic therapies (AATs) in patients with colorectal cancer live …
TRIM56 promotes malignant progression of glioblastoma by stabilizing cIAP1 protein.
Yang X, Zhang Y, Xue Z, Hu Y, Zhou W, Xue Z, Liu X, Liu G, Li W, Liu X, Li X, Han M, Wang J. Yang X, et al. J Exp Clin Cancer Res. 2022 Dec 6;41(1):336. doi: 10.1186/s13046-022-02534-8. J Exp Clin Cancer Res. 2022. PMID: 36471347 Free PMC article.
METHODS: Western blot, real-time quantitative PCR (qRT-PCR), immunofluorescence (IF) and immunohistochemistry (IHC) were used to study the expression levels of TRIM56 and cIAP1 in GBM cell lines. Co-immunoprecipitation (co-IP) was used to explore the specific bindin …
METHODS: Western blot, real-time quantitative PCR (qRT-PCR), immunofluorescence (IF) and immunohistochemistry (IHC) were used to study the e …
Microbial production of valuable chemicals by modular co-culture strategy.
Zhao S, Li F, Yang F, Ma Q, Liu L, Huang Z, Fan X, Li Q, Liu X, Gu P. Zhao S, et al. World J Microbiol Biotechnol. 2022 Nov 8;39(1):6. doi: 10.1007/s11274-022-03447-6. World J Microbiol Biotechnol. 2022. PMID: 36346491 Review.
Recently, modular co-culture strategy has been employed for the synthesis of different natural products. Therefore, in this review, various chemicals produced with application of co-cultivation technology are summarized, including co-culture with same species …
Recently, modular co-culture strategy has been employed for the synthesis of different natural products. Therefore, in this review, v …
Gut microbiota and obesity-associated osteoarthritis.
Liu Y, Ding W, Wang HL, Dai LL, Zong WH, Wang YZ, Bi J, Han W, Dong GJ. Liu Y, et al. Osteoarthritis Cartilage. 2019 Sep;27(9):1257-1265. doi: 10.1016/j.joca.2019.05.009. Epub 2019 May 27. Osteoarthritis Cartilage. 2019. PMID: 31146016 Free article. Review.
TP53 Co-Mutations in Advanced EGFR-Mutated Non-Small Cell Lung Cancer: Prognosis and Therapeutic Strategy for Cancer Therapy.
Liu S, Yu J, Zhang H, Liu J. Liu S, et al. Front Oncol. 2022 Apr 4;12:860563. doi: 10.3389/fonc.2022.860563. eCollection 2022. Front Oncol. 2022. PMID: 35444951 Free PMC article. Review.
However, 20-30% of this subset of patients shows primary resistance to EGFR-TKIs. Patients with co-mutations of EGFR and several other genes have a poor response to EGFR-TKIs, whereas the prognostic and predictive significance of EGFR/TP53 co-mutation in NSCLC patie …
However, 20-30% of this subset of patients shows primary resistance to EGFR-TKIs. Patients with co-mutations of EGFR and several othe …
16,295 results
You have reached the last available page of results. Please see the User Guide for more information.